{Reference Type}: Review
{Title}: Inhaled medications and inhalation chambers for childhood asthma. Spanish network of working groups on asthma in pediatrics (REGAP).
{Author}: Juliá Benito JC;Moreno-Galarraga L;Bragado Alcaraz E;Asensi Monzó MT;Ortega Casanueva C;Moral L;Rodríguez Fernández-Oliva CR;Sanz Ortega J;Valdesoiro Navarrete L;
{Journal}: An Pediatr (Engl Ed)
{Volume}: 100
{Issue}: 2
{Year}: 2024 Feb 6
暂无{DOI}: 10.1016/j.anpede.2024.01.015
{Abstract}: Asthma, the most prevalent chronic disease in pediatric age, continues to pose challenges in its management and treatment. National and international guidelines emphasize the importance of therapeutic education (TE) to achieve disease control. TE involves imparting knowledge and skills to the patient and their family, enhancing medication adherence, rectifying errors in inhalation technique, and tailoring treatment based on individual patient characteristics. It is essential for TE to be progressive, gradual, and personalized, spanning all levels of care. Training healthcare professionals in TE is crucial, particularly for pediatricians, who must also be aware of the extensive variability of available meds and inhalers and their respective age-specific indications. Addressing this need, the REGAP Group extensively reviewed inhalers currently available in Spain for pediatric asthma treatment. The review encompassed different inhalation systems and inhaled drugs used for pediatric asthma treatment. This review will be updated annually, providing information on medications, devices, inhalation chambers, indications, and financiation. The REGAP Group hopes that these tables will be a valuable help for pediatricians in their daily clinical practice and serve as an effective TE tool.